VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ALNY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ALNYAlnylam Pharmaceuticals, Inc.
$313.04$41.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksALNYQuarterly Cash Flow

Alnylam Pharmaceuticals, Inc. (ALNY) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Alnylam Pharmaceuticals, Inc. (ALNY) quarterly cash flow statement — complete operating, investing & financing history

ALNY Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations70.5M163.56M325.11M153.73M-118.31M-94.66M43.71M124.16M-81.52M-29.8M359.41M-58.99M-166.47M-131.98M-115.28M-122.82M-171.19M-150.14M-134.04M-121.86M
Operating CF Margin %6.04%14.91%26.03%19.87%-19.91%-15.96%8.73%18.82%-16.49%-6.78%47.89%-18.51%-52.14%-39.39%-43.62%-54.63%-80.27%-58.07%-71.44%-55.25%
Operating CF Growth %159.59%272.78%643.84%23.82%-45.14%-217.71%-87.84%310.49%51.03%77.42%411.76%51.97%2.76%12.1%13.99%-0.79%27.36%-21.92%-21.49%9.96%
Net Income205.99M186.42M251.08M-66.28M-57.48M-83.76M-111.57M-16.89M-65.94M-137.87M147.75M-276.02M-174.1M-207.49M-405.92M-277.4M-240.34M-258.46M-204.51M-189.56M
Depreciation & Amortization13.55M13.51M13.8M13.94M14.4M-20.55M48.7M15M13.52M13.48M23.53M23.45M26.08M24.89M20.65M30.55M9.46M21.45M23.22M22.16M
Stock-Based Compensation70.15M0108.21M111.68M56.71M91.64M45.8M89.29M45.35M41.99M63.94M75.8M39.95M42.77M128.12M30.47M29.29M44.58M33.37M32.08M
Deferred Taxes9.31M-27.17M5.6M9.73M9.64M000454K-53.1M39.26M28.82M000005.58M-18.69M4.43M
Other Non-Cash Items53.19M63.95M151.07M34.57M75.45M-7.79M30.05M86.06M46.4M98.91M59.41M24.4M27.74M21.54M137.21M60.13M90.36M51.82M33.05M30.41M
Working Capital Changes-281.7M-73.15M-204.66M50.08M-217.05M-74.21M30.73M-49.3M-121.3M6.79M25.53M64.58M-86.14M-13.68M4.65M33.43M-59.96M-15.11M-465K-21.38M
Change in Receivables-110.42M184.25M-399.86M-136.91M-7.43M-59.51M-37.09M9.64M410K3.87M-107.99M-2.97M19.15M-53.27M-38.42M6.4M39.7M-59.45M3.67M-35.31M
Change in Inventory-3.32M-13.86M4.98M11.14M6.21M849K5.92M6.79M22K11.99M4.79M1.99M-403K-18.98M-7.88M-9.2M1.93M-10.76M-13.63M-3.96M
Change in Payables-176.03M0223.51M182.15M-155.74M-62.11M83.59M74.47M-4.87M-38.67M118.74M82.74M-81.97M102.62M69.75M68.14M-48.74M39.5M46.36M41.82M
Cash from Investing-25.54M-37.17M501.11M-141.38M113.77M-52.91M-30.25M33.94M-67.62M-240.66M-10.76M-8.71M-76.22M-139.91M313.89M142.79M-147.42M-413.4M-88.27M157.02M
Capital Expenditures-21.83M-23.29M-12.14M-14.29M-8.97M-9.09M-4.19M-8.02M-12.97M-15.31M-17.09M-15.92M-13.89M-21.64M-16.51M-16.05M-17.86M-21.89M-26.06M-11.25M
CapEx % of Revenue1.87%2.12%0.97%1.85%1.51%1.53%0.84%1.22%2.62%3.48%2.28%4.99%4.35%6.46%6.25%7.14%8.37%8.47%13.89%5.1%
Acquisitions000000000225.35M-10.77M-7.21M-49.23M0000000
Investments--------------------
Other Investing-4.1M0-450K9.25M48.83M-117K000-225.35M6.33M7.21M49.23M381K-5M-8.5M-75K-1K0-165K
Cash from Financing15.71M45.32M-448.35M53.76M44.08M31M102.75M131.5M28.91M39.23M33.14M53.39M46.37M63.44M297.02M30.34M34.96M292.29M573.84M329.81M
Debt Issued (Net)2.57M-61.21M-494.01M0000000000-777K136.17M00250M493.75M243.75M
Equity Issued (Net)13.16M41.7M-130.59M81.22M49.37M36.28M108.04M132.78M25.86M30.89M24.8M49.39M42.37M56.71M153.02M22.5M27.12M45.04M72.39M81.86M
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing-9K64.82M176.25M-27.46M-5.28M-5.28M-5.28M-1.28M3.05M8.33M8.33M4M4M7.5M7.83M7.83M7.83M-2.75M7.7M4.2M
Net Change in Cash53.61M166M376.94M93.61M53.6M-133.85M131.31M286.61M-130.81M-220.34M375.23M-14.44M-194.15M-206.83M497.65M41.48M-285.89M-274.31M348.39M366.06M
Free Cash Flow48.67M140.26M312.97M139.44M-127.28M-103.76M39.52M116.14M-94.49M-45.1M342.32M-74.91M-180.37M-153.61M-131.79M-138.87M-189.05M-172.03M-160.1M-133.1M
FCF Margin %4.17%12.79%25.06%18.02%-21.42%-17.49%7.89%17.6%-19.11%-10.26%45.61%-23.5%-56.49%-45.85%-49.86%-61.77%-88.65%-66.54%-85.33%-60.35%
FCF Growth %138.24%235.19%692.02%20.06%-34.71%-130.04%-88.46%255.05%47.61%70.64%359.74%46.06%4.59%10.7%17.68%-4.34%25.23%-18.79%-30.43%12.43%
FCF per Share0.351.032.281.08-0.98-0.810.310.92-0.75-0.362.61-0.60-1.45-1.25-1.08-1.15-1.57-1.44-1.34-1.13
FCF Conversion (FCF/Net Income)0.34x0.88x1.29x-2.32x2.06x1.13x-0.39x-7.35x1.24x0.22x2.43x0.21x0.96x0.64x0.28x0.44x0.71x0.58x0.66x0.64x
Interest Paid64.2M113.32M23.89M14.56M66.93M12.33M0030.95M00000000000
Taxes Paid2.37M01.28M-1.87M2.97M0001.99M00000000000